DCLK1 integrates induction of TRIB3, EMT, drug resistance and poor prognosis in colorectal cancer.
暂无分享,去创建一个
Y. Doki | M. Mori | T. Mizushima | Hirofumi Yamamoto | D. Okuzaki | N. Miyoshi | N. Haraguchi | T. Hata | C. Matsuda | H. Takahashi | Shunichiro Makino